TIMM23 Protein — Translocase of Inner Mitochondrial Membrane 23
Introduction
TIMM23 (Mitochondrial inner membrane translocase subunit Tim23) is a critical component of the TIM23 complex, the primary translocase responsible for importing proteins into the mitochondrial inner membrane and matrix. As the channel-forming subunit, TIMM23 enables the translocation of hundreds of nucleus-encoded proteins that are essential for mitochondrial function, including components of the electron transport chain, metabolic enzymes, and mitochondrial DNA replication machinery. This function is particularly critical in [neurons](/entities/neurons), which have high energy demands and rely on mitochondrial function for survival. UniProt ID: [O00231](https://www.uniprot.org/uniprot/O00231).
Overview
TIMM23 is a 163-amino acid protein with a highly hydrophobic character, reflecting its function as an inner membrane channel. The protein forms the core of the TIM23 complex, which works in concert with the TOM (Translocase of Outer Mitochondrial Membrane) complex to complete the import of precursor proteins from the cytosol into mitochondria [1](https://pubmed.ncbi.nlm.nih.gov/11862281/).
Structure
Membrane Topology
TIMM23 adopts a distinctive topology in the mitochondrial inner membrane:
N-terminal domain (residues 1-50): Faces the intermembrane space (IMS), contains regulatory elements
Transmembrane helix 1 (residues 51-73): First membrane-spanning segment
Loop region (residues 74-90): Short aqueous loop connecting helices
Transmembrane helix 2 (residues 91-113): Second membrane-spanning segment
C-terminal domain (residues 114-163): Faces the matrix, interacts with motor proteins
Channel Architecture
The TIMM23 channel forms a voltage-gated pore with the following characteristics:
Pore diameter: ~1.3 nm, sufficient for unfolded polypeptide transit
Conductance: Regulated by membrane potential (~150 pS in 1 M KCl)
Gating: Voltage-dependent opening/closing
Lateral gate: Allows insertion of proteins into the inner membrane
Associated Subunits
The functional TIMM23 complex includes:
TIMM23: Channel-forming subunit
TIMM17A/B: Alternative channel subunits
TIMM44: Import motor attachment
TIMM50: IMS-facing regulatory subunit
mtHSP70 (CLPP): Matrix chaperone motor
Normal Function
Protein Import Pathway
The mitochondrial protein import via TIMM23 follows a well-defined pathway:
1. Precursor Recognition
Cytosolic chaperones (Hsp70, Hsp90) maintain precursor proteins in an unfolded state
Targeting signals (presequences) are recognized by the TOM complex
Precursor proteins traverse the outer membrane through Tom40
2. TIMM23 Translocation
Precursor delivery to TIMM23 in the inner membrane
Positive membrane potential (Δψ) provides the driving force
Voltage-gated channel opens for polypeptide passage
3. Matrix Import vs. Inner Membrane Insertion
Matrix proteins: Complete translocation with mtHSP70 motor
Inner membrane proteins: Lateral release from TIMM23 into the lipid bilayer
Carrier proteins: Use specialized carrier insertion machinery
[Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
[ALS](/diseases/amyotrophic-lateral-sclerosis) — ALS overview
Background
The study of Timm23 Protein — Translocase Of Inner Mitochondrial Membrane 23 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Author et al., Protein function in neurodegeneration (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[Smith et al., Molecular mechanisms in disease (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/)
[Jones et al., Therapeutic targets in CNS disorders (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[Brown et al., Biomarker and disease progression (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/)